Clinical Study Results
Research Sponsor: MedImmune, an AstraZeneca company
Drug Studied: MEDI0382, also called cotadutide
Study Title: A study to find out if MEDI0382 changed the amount of
sugar in the blood in participants with type 2 diabetes
and kidney problems
Thank you!
Thank you to the participants who took part in the clinical study for the study drug
MEDI0382, also called cotadutide. All of the participants helped researchers learn
more about MEDI0382 to help people with type 2 diabetes and kidney problems.
MedImmune, an AstraZeneca company, sponsored this study and thinks it is
important to share the results of the study with you and the public.A n independent
non-profit organization called CISCRP helped prepare this summary of the study
results for you. We hope it helps you understand and feel proud of your important
role in medical research.
If you participated in the study and have questions about the results, please speak
with the doctor or staff at your study site.
What is happening with the study now?
Participants were in the study for up to 3.5 months, but the entire study took
9 months to finish. The study started in June 2018 and ended in February 2019.
The study included 41 participants from Germany and the United Kingdom.
The sponsor reviewed the data collected when the study ended and created a
report of the results. This is a summary of that report.
1